Pioneering Australian doctor Richard Scolyer has died, three years after being diagnosed with an aggressive brain tumour.
Scolyer, 59, made global headlines for his decision to undergo a risky world-first experimental treatment for his glioblastoma at the hands of his friend Professor Georgina Long – based on the pair’s own scientific breakthroughs in skin cancer.
Their work on advanced melanoma – once a death sentence – has saved countless lives, and their encouraging findings in treating Scolyer’s brain tumour have triggered an early stage clinical trial in the US.
“I wanted to keep contributing, even in my darkest hour,” Scolyer said in an open letter announcing his death.
“I pen this letter as a final goodbye to all those I have had the immense privilege of loving, sharing life’s adventures with, working alongside and meeting during what can only be described as a life filled with happiness, optimism, opportunity and passion.”
Australia’s Prime Minister Anthony Albanese called Prof Scolyer “one of our brightest lights and one of our biggest hearts”.
“Every day, this remarkable man – the cancer specialist who became his own subject – took us into his confidence, and he lifted us all in the process.”
One of the country’s most respected medical minds, Prof Scolyer became a national treasure. In 2024, he was named Australian of the Year alongside Long.
As co-directors of the Melanoma Institute Australia, over the past decade the pair’s research on immunotherapy, which uses the body’s immune system to attack cancer cells, has dramatically improved outcomes for advanced melanoma patients globally. Half are now essentially cured, up from less than 10%.
Scolyer also pointed to the mentoring of up-and-coming pathologists as a source of pride in his career. (BBC)
